1. Home
  2. STRO vs EOT Comparison

STRO vs EOT Comparison

Compare STRO & EOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$9.92

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Logo Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

EOT

Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

HOLD

Current Price

$16.58

Market Cap

265.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
EOT
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Investment Bankers/Brokers/Service
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
85.0M
265.6M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STRO
EOT
Price
$9.92
$16.58
Analyst Decision
Hold
Analyst Count
7
0
Target Price
$19.67
N/A
AVG Volume (30 Days)
121.9K
38.7K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
4.51%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$105,646,000.00
N/A
Revenue This Year
$62.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.23
$14.63
52 Week High
$21.50
$18.30

Technical Indicators

Market Signals
Indicator
STRO
EOT
Relative Strength Index (RSI) 78.91 50.61
Support Level $9.53 $16.45
Resistance Level $10.10 $16.77
Average True Range (ATR) 0.93 0.19
MACD 0.15 0.01
Stochastic Oscillator 98.52 71.43

Price Performance

Historical Comparison
STRO
EOT

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About EOT Eaton Vance Municipal Income Trust EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST

Eaton Vance National Municipal Opportunities Trust is a diversified, closed-end management investment company. The company's investment objective is to provide current income exempt from regular federal income tax and to achieve capital appreciation. The company invests a majority of its assets in debt obligations issued by or on behalf of states, territories, and possessions of the United States, including the District of Columbia, and their political subdivisions, agencies, or instrumentalities, the interest on which is exempt from regular federal income tax.

Share on Social Networks: